Global Artesunate Tablet Market Growth 2025-2031

Global Artesunate Tablet Market Growth 2025-2031

The global Artesunate Tablet market size is predicted to grow from US$ 175 million in 2025 to US$ 251 million in 2031; it is expected to grow at a CAGR of 6.2% from 2025 to 2031.

Artesunate (AS) is a medication used to treat malaria. The intravenous form is preferred to quinidine for severe malaria. Often it is used as part of combination therapy. It is not used for the prevention of malaria.

Global Artesunate Tablet main players include Fosun Pharma (Guilin), Ipca Laboratories, Sanofi Aventis, Ajanta Pharma, Shin Poong, Cipla, Acino, MCW Healthcare, etc., totally accounting for about 70%. Central and South America is the largest market, with a share over 75%. As for the types of products, it can be divided into PA 90 Content, PA 95 Content and PA 98 Content. The most common product is Monoaromatic Artesunate and Compound Artesunate. In terms of applications, it is widely used in Hospital, Clinic and Others. The most application is in Hospital, with a share over 67%.

LP Information, Inc. (LPI) ' newest research report, the “Artesunate Tablet Industry Forecast” looks at past sales and reviews total world Artesunate Tablet sales in 2024, providing a comprehensive analysis by region and market sector of projected Artesunate Tablet sales for 2025 through 2031. With Artesunate Tablet sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Artesunate Tablet industry.

This Insight Report provides a comprehensive analysis of the global Artesunate Tablet landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Artesunate Tablet portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Artesunate Tablet market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Artesunate Tablet and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Artesunate Tablet.

This report presents a comprehensive overview, market shares, and growth opportunities of Artesunate Tablet market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Monoaromatic Artesunate
Compound Artesunate

Segmentation by Application:
Hospital
Clinic
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Fosun Pharma (Guilin)
Ipca Laboratories
Sanofi Aventis
Ajanta Pharma
Shin Poong
Cipla
Acino
MCW Healthcare

Key Questions Addressed in this Report

What is the 10-year outlook for the global Artesunate Tablet market?

What factors are driving Artesunate Tablet market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Artesunate Tablet market opportunities vary by end market size?

How does Artesunate Tablet break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.